-
Mashup Score: 0Should NICE’s cost-effectiveness thresholds change? - 56 minute(s) ago
We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds. Cost-effectiveness thresholds play a vital role in healthcare decision-making, helping to ensure that NHS resources are used efficiently and fairly. As NICE’s programme director for medicines evaluation, I explore some of the ongoing discussions around this topic and explain why NICE uses its current thresholds. At NICE, we’ re tasked with ensuring that the NHS uses its finite budget effectively. Any new
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 14EJM - Econ Job Market - 1 month(s) ago
The automated language-translation service on econjobmarlet.org is provided free by Google Translate, a third party service. Google is wholly responsible for the tra nslation service. Econ Job Market Inc. does not guarantee or warrant the reliability, accuracy, or completeness of any translated text. Before acting on any translated text, you should verify its fidelity in relation to the original text shown on econjobmarlet.org. Advertiser: Business School, Imperial College London Position type(s):
Source: econjobmarket.orgCategories: General Medicine News, Hem/OncsTweet-
RT @Samantha_Burn: My department @ImperialBiz is hiring: https://t.co/l7yBm7twl7 Apply by November 25! Open to all fields/all levels. It's…
-
-
Mashup Score: 2Payments by Drug and Medical Device Manufacturers to US Peer Reviewers of Major Medical Journals - 2 month(s) ago
This study characterizes payments by drug and medical device manufacturers to US peer reviewers of major medical journals.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
"Peer reviewers... received $64.18 million in general payments between 2020 & 2022, representing a median general payment of $7614... Additional research & transparency regarding industry payments in the peer review process are needed" via @JAMA_current https://t.co/DmT4NJe1El
-
-
Mashup Score: 5Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa—Reply - 3 month(s) ago
In Reply Chen and colleagues raise 2 important points in response to our analysis of beremagene geperpavec (B-VEC) therapy1: the high costs of therapy may be offset by reductions in other health care costs, and cost-effectiveness analysis (CEA) would help assess the value of B-VEC therapy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Our reply.. to a reply.. to our analysis of B-VEC for dystrophic epidermolysis bullosa out in @JAMADerm. Short version: while total spending is a consideration for B-VEC therapy, cost-effectiveness analysis (using #QALYs) would better capture it's value. https://t.co/uNGoNH5rpb
-
-
Mashup Score: 0Greenhouse Gas Emissions and Costs of Inhaler Devices in the US - 4 month(s) ago
This study assesses mean emissions and costs and estimated total yearly emissions and costs for US-branded inhalers prescribed to Medicare Part D and Medicaid beneficiaries.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
'Inhaler prescriptions filled by CMS beneficiaries in 2022 resulted in an estimated 1.15 MMT of CO2e emissions, equivalent to 226 960 homes’ yearly electricity use.' via @JAMA_current https://t.co/2azTTJ6Laq
-
-
Mashup Score: 4Tanker traffic increases tenfold in B.C.'s Burrard Inlet following Trans Mountain pipeline expansion | CBC News - 4 month(s) ago
Data collected by a Simon Fraser University professor, which has been corroborated by Trans Mountain, shows that tanker traffic in Vancouver’s Burrard Inlet has increased tenfold since the company’s expanded pipeline came online this summer.
Source: www.cbc.caCategories: General Medicine News, Hem/OncsTweet-
'Data collected by a @SFU professor shows that tanker traffic in Vancouver's Burrard Inlet has increased tenfold since the expanded Trans Mountain pipeline came online this summer.' #vanpoli #bcpoli https://t.co/b1u5RsPG5T
-
-
Mashup Score: 3
Centre for the Business and Economics of Health (CBEH) Lead a Centre committed to translating research into policy and practice to impact economic, social and health outcomes. Shape the future of CBEH and help improve healthcare service delivery and population health outcomes across Australia Closing date: 22 August 2024 at 11pm AEST. Centre for the Business and Economics of Health The University of Queensland’s Centre for the Business and Economics of Health (CBEH) applies economics and business expertise to inform decisions for better health outcomes. Through priority-led research and thought leadership, CBEH researchers analyse critical issues and influence improvements across the range of health and healthcare settings. The Faculty of Business, Economics and Law (BEL) and the Faculty of Health and Behavioural Sciences (HaBS) – which as of January 2025 will formally be the Faculty of Health, Medicine and Behavioural Sciences (HMBS) – are jointly recruiting a Director for the Centre.
Source: uq.wd3.myworkdayjobs.comCategories: General Medicine News, Hem/OncsTweet-
RT @LenzenSabrina: We are hiring a new Director of Health Economics at UQ! https://t.co/lN93OURaTU
-
-
Mashup Score: 2Wildfires and Human Health - 5 month(s) ago
This JAMA Insights explores the adverse effects of wildfires on human health and health care systems and offers suggestions on how clinicians can help mitigate the health threats posed by wildfires.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
'Vulnerable populations include children, older patients with multiple comorbidities, those living in wildfire-prone areas, unhoused individuals, and those from low socioeconomic backgrounds.' by @r_fadadu, @GinaSolomonMD, J Balmes Via @JAMA_current 🌎 https://t.co/1VHO7o3Ebp
-
-
Mashup Score: 8Postdoctoral Fellow – Evgin Lab | Genome Sciences Centre - 5 month(s) ago
Canada’s Michael Smith Genome Sciences Centre (GSC) Today’s Research. Tomorrow’s Medicine.
Source: www.bcgsc.caCategories: General Medicine News, Hem/OncsTweet-
RT @EvginLab: We are looking for a postdoctoral fellow to join our lab at @BCCancer_GSC. Apply here:https://t.co/HIDwURUVYx. Read more abou…
-
-
Mashup Score: 16Home - 6 month(s) ago
29 November 2023
Source: sites.google.comCategories: General Medicine News, Hem/OncsTweet-
🌎New post! 🌎 Featuring new research by @HensherMartin on the complexities of degrowth & healthcare. Also, work published in @JAMAOnc from researchers at @radboudumc on promoting environmental/financial sustainability by redispensing anticancer drugs. https://t.co/txeftrrMKI https://t.co/6psHDjnmHe
-
Curious about cost-effectiveness thresholds? There's lots of misconceptions and misinterpretations about what they are (& what they aren't). Check out this excellent post by Dr Jacoline Bouvy at NICE in the UK. #healtheconomics https://t.co/iHPO8yUD28